ClinicalTrials.govpublic full text
Docetaxel and Imatinib Mesylate in Treating Patients With Androgen-Independent Prostate Cancer and Bone Metastases That Progressed on the Docetaxel and Placebo Group of MDA-ID-030008
metastatic cancer, prostate cancer, adenocarcinoma of the prostate, recurrent prostate cancer, stage iv prostate cancer, bone metastases, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 827049
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.